Additionally, the proportion of CCR2-RFP+ CD11b+ cells remains unchanged by experimental stroke (Figure 3D) meaning it is unlikely that TipDC and moDC, which are both derived from recruited monocytes under conditions of inflammation contribute to increased CD11b+ cells in the spleen after stroke. Here, CCR2 is linked to stroke disorder.